PharmaCom BioVet, Inc.
Limited financial coverage for PHMB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions.
- CEO
- Ira Frohman
- IPO
- 1999
- HQ
- Raleigh, NC, US
Price Chart
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.74
- Avg Volume
- 93.60K
Get TickerSpark's AI analysis on PHMB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PHMB coverage
Recent articles, reports, and earnings notes.
No research on PHMB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHMB report →Similar companies
Peers in the same neighborhood.